Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02734576 · ClinicalTrials.gov registry record · NA

Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis

A NA study, sponsored by Weill Medical College of Cornell University.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT02734576 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02734576, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

There have been few published studies that examine the efficacy and safety of endovascular treatments on patients with pulsatile tinnitus with venous stenosis. Despite the limited experience with venous sinus stenting to treat pulsatile tinnitus, preliminary results show that venous sinus stenting could represent a viable alternative for refractory pulsatile tinnitus patients with venous sinus stenosis. The purpose of this study is to evaluate the safety and efficacy of this procedure in a controlled fashion, using strict inclusion and exclusion criteria, and long-term clinical and imaging follow-up. The investigators hope to provide robust data regarding the safety and efficacy of venous sinus stenting for patients with pulsatile tinnitus.

Interventions

  • DEVICE Venous Sinus Stenting with the Precise Pro Stent

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-01-24
Est. Completion 2020-03-01
Phase NA

What the Registry Record Tells You About NCT02734576

The ClinicalTrials.gov registry entry for NCT02734576 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Venous Sinus Stenting with the Precise Pro Stent is the first listed.

NCT02734576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02734576 about?

NCT02734576 is a clinical study titled "Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis". There have been few published studies that examine the efficacy and safety of endovascular treatments on patients with pulsatile tinnitus with venous stenosis. Despite the limited experience with venous sinus stenting to treat pulsatile tinnitus, preliminary results show that venous sinus stenting c...

What is the current status of trial NCT02734576?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2017-01-24. Estimated completion is 2020-03-01.

What interventions are being tested in trial NCT02734576?

The interventions under investigation include: Venous Sinus Stenting with the Precise Pro Stent (DEVICE).

Who is sponsoring clinical trial NCT02734576?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.